Skip to content

BMJ

ISSN 0959-8138; 1756-1833;

40 papers in the library · 992 citations · publishing 1951-2026

Papers

Sort Most recent Most cited

Zoonotic potential of emerging animal diseases

BMJ November 24, 2005 Samson S. Y. Wong, Kwok‐Yung Yuen 2 citations

Abstract 5-Methoxy-N,N-dimethyltryptamine (acronymized as 5-MeO-DMT) is sui generis among the numerous naturally-occurring psychoactive substances due to its unparalleled ego-dissolving effects which can culminate in a state of nondual consciousness (which is phenomenologically similar to transformative peak experiences described in various ancient contemplative traditions, e.g., Advaita...

…such as ketamine

BMJ August 17, 1996 David Shewan, Phil Dalgarno, Leslie A. King 14 citations

EDITOR,—There is increasing concern over the toxic1 and neurodegenerative2 effects of ecstasy, and further research is clearly required. Potential hazards can also, however, arise through use of tablets sold as ecstasy that contain substances other than ecstasy, such as ketamine. Ketamine is an anaesthetic agent with a rapid action that has medical and veterinary applications. Drug users who...

Cerebral oedema after ingestion of MDMA (“ecstasy”) and unrestricted intake of water

BMJ May 25, 1996 S M Matthai, J A Sills, D C Davidson et al. 68 citations

EDITOR,—3, 4-Methylenedioxymethamphetamine (MDMA or “ecstasy”) is a synthetic derivative of amphetamine and a popular recreational drug among young people. It is known to cause severe hyperpyrexia, dehydration, and rhabdomyolysis.1 Unrestricted ingestion of water is commonly believed to be important in combating some of the side effects of ingestion of the drug. We report on two patients who...

Chronic paranoid psychosis after misuse of MDMA ("ecstasy")

BMJ March 23, 1991 Philip Mcguire, Thomas Fahy 128 citations

Methylenedioxymetamphetamine (MDMA, "ecstasy") is a hallucinogenic amphetamine that combines the effects of amphetamines and lysergic acid diethylamide (LSD) and has become increasingly popular in the United Kingdom.We report two cases of chronic paranoid psychoses after heavy misuse of this drug. Case reports CASE I

Abuse of the mushroom Panaeolus foenisecii.

BMJ February 16, 1980 P Cooles 18 citations

CommentReports on the presence of psilocybin and psilocin in Panaeolus foenesecii are confused, since both have been detected in some samples of this mushroom but not in all.It is usually considered a "latent psilocybin" mushroom, because psilocybin and psilocin may not necessarily be present in a particular specimen.

Steam sterilisation of sandpits infected with toxocara eggs.

BMJ May 19, 1979 F. van Knapen, J.h. Franchimont, G M Otter 21 citations

The law was subsequently changed to make possession of the plant illegal.Thus unless the Act is amended to name the psilocybin mushroom possession is legal.Apparently increasing numbers of teenagers and others are harvesting and eating the mushrooms.2Doctors should therefore be aware of possible long-term side effects of such agents.One of these is the flashback phenomenon described by about 5%...

Toxic Effect of Proguanil

BMJ August 18, 1951 Peter Abbott

Abstract Background Neuroimaging studies have just begun to explore the acute effects of psychedelics on large-scale brain networks’ functional organization. Even less is known on the neural correlates of subacute effects taking place days after the psychedelic experience. This study explores the subacute changes of primary sensory brain networks and networks supporting higher-order affective...